# IGC Pharma, Inc.: Form 8-K, filed Oct 27, 2023

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2023-10-27
- Accepted by EDGAR: Oct 27, 2023, 17:21 ET
- Period: 2023-10-27
- Accession: 0001185185-23-001111
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518523001111/igcpharma20231027_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518523001111/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518523001111/igcpharma20231027_8k.htm

Filed Oct 27, 2023.
Source: SEC EDGAR, the filing index for accession 0001185185-23-001111. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.